Cellosaurus logo
expasy logo

Cellosaurus AC-33 (CVCL_Z046)

[Text][XML][JSON]
Cell line name AC-33
Accession CVCL_Z046
Resource Identification Initiative To cite this cell line use: AC-33 (RRID:CVCL_Z046)
Comments Group: Hybridoma fusion partner cell line.
Group: Patented cell line.
Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-2143.
Population: Caucasian.
Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
Cell type: B-cell; CL=CL_0000236.
Sequence variations
  • Mutation; HGNC; HGNC:11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from parent cell line).
Disease Hereditary spherocytosis (NCIt: C97074)
Hereditary spherocytosis (ORDO: Orphanet_822)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_6544 (WIL2)
Sex of cell Male
Age at sampling 5Y
Category Transformed cell line
Publications

Patent=US5126259
Hiroko Tada, Yukio Toyoda, Atsushi Kakinuma;
Human b lymphoblastoid cell, hybridoma, antibody and production of antibody.
Patent number US5126259, 30-Jun-1992

Cross-references
Cell line collections (Providers) JCRB; IFO50155 - Discontinued
Encyclopedic resources Wikidata; Q54607870
Entry history
Entry creation10-Apr-2015
Last entry update10-Apr-2025
Version number14